Pfizer Inc PFE
News
Pfizer and Blackstone Life Sciences Announce Strategic Funding Agreement for Obesity Program
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
Election Day Trading Splits the Benchmarks, With the Dow Lower and the Nasdaq Higher
Pfizer Raises Forecast on Momentum With New Products — Update
Pfizer Raises Forecast on Momentum With New Products
Pfizer Names Cecile Guegan Permanent Chief Financial Officer
Pfizer Reports Strong Third-Quarter 2026 Results And Raises 2026 Guidance
Pfizer Appoints Cecile Guegan as Chief Financial Officer
Dow Futures Fall, Treasurys Yields Rise Heading Into Midterms
Looking for income? These dividend stocks have high yields that seem well supported.
Pfizer’s ELREXFIO Outperforms Standard Regimens and Meets Primary Endpoint in Phase 3 Study in Relapsed or Refractory Multiple Myeloma
Pfizer’s TALZENNA Plus XTANDI FDA-Approved for an Earlier Metastatic Prostate Cancer Treatment Setting
Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026
Pfizer Showcases Clinical Advancements Across Infectious Diseases at IDWeek 2026
Pfizer Gets FDA Approval for Expanded Use of Breast-Cancer Treatment Tukysa
Pfizer’s TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer
Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026
Pfizer Declares Fourth-Quarter 2026 Dividend
Vaxcyte Reports Bacterial-Infection Vaccine Met Primary Endpoints in Phase 3 Trial


